A recently retired U.S. senator is calling on the Arizona legislature to pass a bill to fund clinical trials into ibogaine, while pledging to personally raise $5 million in philanthropic donations to support the psychedelic research if the legislation is ultimately enacted.
At an Arizona House Appropriations Committee hearing on Monday, members discussed the legislation from Rep. Justin Wilmeth (R), which would provide funding for the state Department of Health and Human Services (HHS) to “conduct a certified clinical research study on the use of ibogaine for the treatment of neurological diseases.”
“The goal of the ask is simple: Make Arizona the hub of a revolutionary treatment to help our veterans,” the sponsor said in opening remarks. He then welcomed one of the measure’s supporters: former U.S. Sen. Kyrsten Sinema (I-AZ), who also championed psychedelics reform while serving in Congress.
Sinema said that, as a former licensed clinical social worker, she understands the limitations of conventional therapy options for people suffering from conditions such as traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD).
“Traditional psychotropic medications such as SSRIs and mood stabilizers range between only 20 and 40 percent effective. So clearly, the current arsenal of tools are not
Read full article on Marijuana Moment
